Key Points
FFNTF stock trades at $0.00001 with 99.67% annual decline.
Company faces negative cash flow, 94% net loss margin, and $70M working capital deficit.
Cannabis operator generates $0.15 revenue per share but cannot cover 65% administrative cost ratio.
Earnings due May 25 expected to show continued losses and operational deterioration.
4Front Ventures Corp. (FFNTF) trades at $0.00001 per share on the OTC Pink Markets (PNK), reflecting severe distress in the cannabis sector. The Phoenix-based operator manages licensed cannabis facilities across Massachusetts, Illinois, and Michigan under the MISSION brand. With a market cap of just $12,460 and 1.25 billion shares outstanding, FFNTF stock has collapsed 99.67% over the past year. The company operates two segments: THC Cannabis and CBD Wellness. Despite 374 full-time employees, the business faces mounting losses and negative cash flow dynamics that have eroded shareholder value dramatically.
FFNTF Stock Performance and Market Metrics
FFNTF stock trades at penny levels with virtually no daily price movement. The stock hit a 52-week high of $0.0742 but has since plummeted to $0.00001, representing a devastating 99.67% decline. Trading volume spiked to 50,000 shares today, though average daily volume sits at just 1 share, indicating extreme illiquidity. The 50-day moving average stands at $0.0000388, while the 200-day average is $0.00015475, both far above current levels.
The enterprise value reaches $206.5 million despite the microscopic market cap, creating a massive valuation disconnect. This suggests substantial debt obligations and liabilities overshadow equity value. The price-to-sales ratio of 0.000128 appears cheap on paper, but negative earnings make traditional valuation metrics unreliable for distressed cannabis operators.
Financial Deterioration and Cash Flow Crisis
4Front Ventures faces severe financial deterioration across all profitability metrics. The company posted a negative EPS of -$0.11, with a net profit margin of -94.06%, meaning every dollar of revenue generates massive losses. Operating cash flow per share turned negative at -$0.0028, while free cash flow per share deteriorated to -$0.0080, signaling the business burns cash operationally.
Working capital collapsed to -$70.1 million, indicating the company cannot cover short-term obligations with current assets. The current ratio of 0.326 means FFNTF has only 33 cents in liquid assets for every dollar of liabilities due within 12 months. Debt-to-assets ratio of 0.795 shows the balance sheet is 79.5% financed by debt, leaving minimal equity cushion for creditors or shareholders.
Operational Challenges in Cannabis Retail
The cannabis retail segment operates six dispensaries across three states, generating revenue of approximately $0.15 per share on a trailing twelve-month basis. However, gross profit margin of 47.1% cannot offset operating expenses consuming 21.4% of revenue, plus administrative costs at 65.1% of sales. This cost structure leaves no room for profitability at current scale.
Inventory turnover of 3.02x means cannabis products sit in stock for 121 days on average, tying up working capital in slow-moving inventory. Days sales outstanding of 31.5 days suggests collection challenges from retail partners. The company’s earnings announcement scheduled for May 25, 2026, will likely reveal continued operational losses and cash burn.
Market Sentiment and Technical Signals
Technical indicators show mixed signals with RSI at 46.33, suggesting neutral momentum without clear directional bias. The MACD histogram sits at zero with no trend confirmation, while ADX at 9.87 indicates no established trend. The Rate of Change (ROC) at -80% reflects the severe downtrend over recent periods, though from such depressed levels, any recovery would appear dramatic.
Money Flow Index at 59.58 suggests moderate buying interest despite the stock’s collapse, possibly from distressed value hunters. However, the On-Balance Volume of -1,076,453 indicates net selling pressure. Track FFNTF on Meyka for real-time updates on this volatile OTC security.
Final Thoughts
FFNTF stock represents a deeply distressed cannabis operator trading at penny levels with minimal liquidity and severe financial deterioration. The company’s negative cash flow, collapsing working capital, and debt-heavy balance sheet create substantial risk for remaining shareholders. With earnings due May 25, 2026, investors should expect continued losses and cash burn disclosures. The cannabis sector’s regulatory uncertainty and oversupply dynamics have crushed valuations across the industry. Meyka AI rates FFNTF with a grade of B based on sector comparison and fundamental metrics, though this reflects relative positioning within distressed cannabis stocks rather than investment qualit…
FAQs
FFNTF trades at $0.00001 per share on OTC Pink Markets, down 99.67% over the past year with minimal trading volume indicating severe illiquidity.
FFNTF collapsed due to negative earnings (-$0.11 EPS), massive operating losses (94% net margin), negative free cash flow, and cannabis sector headwinds limiting profitability.
4Front operates licensed MISSION cannabis dispensaries in Massachusetts, Illinois, and Michigan, plus sells equipment and supplies across THC Cannabis and CBD Wellness segments.
Meyka AI rates FFNTF with a B grade suggesting HOLD. This factors in S&P 500 comparison and sector performance, though grades aren’t guaranteed investment guidance.
4Front’s earnings announcement is scheduled for May 25, 2026, at 12:00 PM UTC, with expected disclosure of operating losses and negative cash flow metrics.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask Meyka Analyst about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)